BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 247 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $242,000 | -27.3% | 1,600 | -30.0% | 0.01% | -16.7% |
| Q2 2022 | $333,000 | +39.3% | 2,286 | +13.3% | 0.01% | +50.0% |
| Q1 2022 | $239,000 | -12.8% | 2,018 | +1.5% | 0.00% | -20.0% |
| Q4 2021 | $274,000 | -1.1% | 1,988 | 0.0% | 0.01% | -16.7% |
| Q3 2021 | $277,000 | +8.2% | 1,988 | -24.8% | 0.01% | +20.0% |
| Q2 2021 | $256,000 | +42.2% | 2,643 | +0.2% | 0.01% | +25.0% |
| Q1 2021 | $180,000 | -34.8% | 2,638 | -18.1% | 0.00% | -50.0% |
| Q4 2020 | $276,000 | +27500.0% | 3,222 | +15242.9% | 0.01% | – |
| Q3 2020 | $1,000 | -50.0% | 21 | 0.0% | 0.00% | – |
| Q2 2020 | $2,000 | 0.0% | 21 | -30.0% | 0.00% | – |
| Q4 2019 | $2,000 | – | 30 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 1,111,111 | $107,867,000 | 52.60% |
| Knoll Capital Management, LLC | 856,844 | $83,182,000 | 43.44% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,082,555 | $202,174,000 | 27.86% |
| ARS Investment Partners, LLC | 558,286 | $54,198,000 | 5.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $17,113,000 | 4.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 401,006 | $38,930,000 | 4.51% |
| Eventide Asset Management | 1,990,797 | $193,267,000 | 2.60% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 56,626 | $5,497,000 | 2.45% |
| Avidity Partners Management LP | 882,500 | $85,673,000 | 2.32% |
| Nicholas Investment Partners, LP | 363,708 | $35,309,000 | 2.22% |